Renal Disorders with Oral Tyrosine Kinase Inhibitors in Metastatic Colorectal Cancer: An Analysis from the FDA Adverse Event Reporting System Database

Background: this study assessed the nephrotoxicity of regorafenib (REG) and encorafenib (ENC) in metastatic colorectal cancer (mCRC) through an analysis of reports from the US Food and Drug Administration’s Adverse Event Reporting System (FAERS) database. Methods: descriptive and disproportional ana...

Descripción completa

Detalles Bibliográficos
Autores principales: Russo, Giulia, Barbieri, Maria Antonietta, Sorbara, Emanuela Elisa, Cicala, Giuseppe, Franchina, Tindara, Santarpia, Mariacarmela, Silvestris, Nicola, Spina, Edoardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452753/
https://www.ncbi.nlm.nih.gov/pubmed/37626807
http://dx.doi.org/10.3390/biomedicines11082311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452753/
https://www.ncbi.nlm.nih.gov/pubmed/37626807
http://dx.doi.org/10.3390/biomedicines11082311

Ejemplares similares